Preferred Label : lomefloxacin;
MeSH note : structure given in first source;
CISMeF synonym : 98079-52-8 (lomefloxacin hydrochloride); NY 198; SC 4711; décalogiflox; maxaquin; novartis brand of lomefloxacin hydrochloride; novartis ophthalmics brand of lomefloxacin hydrochloride; ocacin; okacyn; pharmacia brand 1 of lomefloxacin hydrochloride; pharmacia brand 2 of lomefloxacin hydrochloride;
MeSH synonym : 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic
acid; lomenfloxacin;
MeSH hyponym : Logiflox; Okacin; SC-4711; NY-198;
MeSH CAS label : 3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-,
monohydrochloride;
MeSH Related Number : lomefloxacin hydrochloride; 98079-51-7 (lomefloxacin); 9VC7S3ZXXB;
Registry Number MeSH : 98079-51-7;
Related CAS MeSH : 9VC7S3ZXXB (lomefloxacin hydrochloride);
related registry number list (CISMeF) : 98079-52-8 (HCl);
Is substance : O;
UNII : L6BR2WJD8V;
InChIKey : ZEKZLJVOYLTDKK-UHFFFAOYSA-N;
Origin ID : C053091;
UMLS CUI : C0065162;
ATC code(s)
ATC code(s)
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://sante.fr/lomefloxacine
2019
false
false
false
France
French
patient education handout
lomefloxacin
lomefloxacin
fluoroquinolones
anti-bacterial agents
---
http://www.has-sante.fr/portail/jcms/c_2746924/fr/logiflox-decalogiflox
2017
false
false
France
French
antibiotic therapy
pyelonephritis
prostatitis
lomefloxacin
administration, oral
fluoroquinolones
lomefloxacin
insurance, health, reimbursement
anti-bacterial agents
adult
treatment outcome
cystitis
acute disease
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-01/decalogiflox-logiflox_-_ct-_8373.pdf
http://www.has-sante.fr/portail/jcms/c_1019685/decalogiflox-logiflox
2011
France
French
antibiotic therapy
lomefloxacin
administration, oral
fluoroquinolones
lomefloxacin
insurance, health, reimbursement
anti-bacterial agents
adult
treatment outcome
cystitis
acute disease
fluoroquinolones
evaluation of the transparency committee
---